131 related articles for article (PubMed ID: 34673725)
1. Anesthetic Effects on the Progression of Parkinson Disease in the Rat DJ-1 Model.
Xu DA; DeYoung TP; Kondoleon NP; Eckenhoff RG; Eckenhoff MF
Anesth Analg; 2021 Nov; 133(5):1140-1151. PubMed ID: 34673725
[TBL] [Abstract][Full Text] [Related]
2. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
Ding W; Lin H; Hong X; Ji D; Wu F
Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
[TBL] [Abstract][Full Text] [Related]
3. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
4. Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning.
Kinoshita K; Tada Y; Muroi Y; Unno T; Ishii T
Life Sci; 2015 Sep; 137():28-36. PubMed ID: 26209139
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
[TBL] [Abstract][Full Text] [Related]
6. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
Giangrasso DM; Furlong TM; Keefe KA
Neurobiol Dis; 2020 Feb; 134():104673. PubMed ID: 31734455
[TBL] [Abstract][Full Text] [Related]
7. Age-related vulnerability to nigral dopaminergic degeneration in rats via Zn
Nakajima S; Saeki N; Tamano H; Nishio R; Katahira M; Takeuchi A; Takeda A
Neurotoxicology; 2021 Mar; 83():69-76. PubMed ID: 33400970
[TBL] [Abstract][Full Text] [Related]
8. DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65.
Lin Z; Chen C; Yang D; Ding J; Wang G; Ren H
Cell Death Dis; 2021 Jul; 12(8):715. PubMed ID: 34274951
[TBL] [Abstract][Full Text] [Related]
9. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
Parra I; Martínez I; Ramírez-García G; Tizabi Y; Mendieta L
Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
eNeuro; 2017; 4(1):. PubMed ID: 28303260
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.
Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA
PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145
[TBL] [Abstract][Full Text] [Related]
13. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
14. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease.
Sugama S; Sekiyama K; Kodama T; Takamatsu Y; Takenouchi T; Hashimoto M; Bruno C; Kakinuma Y
Brain Behav Immun; 2016 Jan; 51():39-46. PubMed ID: 26291405
[TBL] [Abstract][Full Text] [Related]
15. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice.
Nguyen TA; Frank-Cannon T; Martinez TN; Ruhn KA; Marvin M; Casey B; Treviño I; Hong JJ; Goldberg MS; Tansey MG
J Neuroinflammation; 2013 Apr; 10():50. PubMed ID: 23622116
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
Ojha S; Javed H; Azimullah S; Abul Khair SB; Haque ME
Drug Des Devel Ther; 2015; 9():5499-510. PubMed ID: 26504373
[TBL] [Abstract][Full Text] [Related]
17. n-3 polyunsaturated fatty acids inhibit lipopolysaccharide-induced microglial activation and dopaminergic injury in rats.
Ji A; Diao H; Wang X; Yang R; Zhang J; Luo W; Cao R; Cao Z; Wang F; Cai T
Neurotoxicology; 2012 Aug; 33(4):780-8. PubMed ID: 22406923
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
[TBL] [Abstract][Full Text] [Related]
19. FTY720 Inhibits MPP
Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
[TBL] [Abstract][Full Text] [Related]
20. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
